Library — CHDR

Search

Filter

Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.

Klumpers LE, Cole DM, Khalili-Mahani N, Soeter RP, Te Beek ET, Rombouts SA, van Gerven JM

NeuroImage, 2012 Nov; 63(3):1701-11

View publication
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

Liem-Moolenaar M, de Boer P, Timmers M, Schoemaker RC, van Hasselt JG, Schmidt S, van Gerven JM

British journal of clinical pharmacology, 2011 May; 71(6):886-98

View publication
A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.

Jacobs GE, van Gerven JM, de Kam Ml, Elassaiss-Schaap J, Ruigt G, van Pelt J, Peeters BW, Peeters PA, Hulskotte EG

Journal of psychopharmacology (Oxford, England), 2011 Feb; 25(3):361-9

View publication
Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers.

Zoethout RW, Delgado WL, Ippel AE, Dahan A, van Gerven JM

British journal of clinical pharmacology, 2011 Feb; 71(3):331-50

View publication
Metoclopramide as pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal (HPA) axis: a study in healthy volunteers.

Jacobs GE, Hulskotte EG, de Kam ML, Zha G, Jiang J, Hu P, Zhao Q, van Pelt J, Goekoop JG, Zitman FG, van Gerven JM

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010 Nov; 20(12):866-74

View publication
Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers.

Zuurman L, Passier PC, de Kam ML, Kleijn HJ, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1689-96

View publication
Central nervous system effects of haloperidol on THC in healthy male volunteers.

Liem-Moolenaar M, te Beek ET, de Kam ML, Franson KL, Kahn RS, Hijman R, Touw D, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1697-708

View publication
The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.

Liem-Moolenaar M, Zoethout RW, de Boer P, Schmidt M, de Kam ML, Cohen AF, Franson KL, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1671-9

View publication
The role of the noradrenergic system in the exploration-exploitation trade-off: a psychopharmacological study.

Jepma M, Te Beek ET, Wagenmakers EJ, van Gerven JM, Nieuwenhuis S

Frontiers in human neuroscience, 2010 Apr

View publication

«
1
2
3
4
5
6
7
»